CAS No. 5700-55-0

3H-Phenoxazine-1,9-dicarboxamide,2-amino-N,N'-bis[(dimethylamino)methyl]-4,6-dimethyl-3-oxo-

Imidazolidinetrione, butyl[4-chloro-5-(cyclopentyloxy)-2-fluorophenyl]-

Ethanone,1-[3-[2-(acetyloxy)ethoxy]-4-(phenylmethoxy)phenyl]-2-bromo-

Formic acid, compd. with O-(pentafluorophenyl)methyl[4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]carbamothioate(1:1)

1-Naphthalenamine, 2-[(1Z)-2-phenyl-1-propenyl]-

Ethanone,1-[4,5-dihydro-5-imino-4-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-

71687-15-5

Ethanone,1-[4-[(1E)-2-phenylethenyl]phenyl]-2-(triphenylphosphoranylidene)-

Formic acid, compd. withN-(3S)-1-azabicyclo[2.2.2]oct-3-yl-5-(cyclopropylmethoxy)-1H-indazole-3-carboxamide (1:1)

Imidazo[5,1-f][1,2,4]triazin-2-amine,N-(4-methoxyphenyl)-5-methyl-7-(phenylmethyl)-

Ethanone,1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-(3-heptyl-2,3-dihydro-2-imino-1H-benzimidazol-1-yl)-

Formic acid, compd. with1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinemethanol (1:1)

Formamide,N-[2-hydroxy-5-[2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-

477552-93-5

Alcohols, C12-14-secondary, ethoxylated, reaction products

Imidazo[5,1-f][1,2,4]triazin-4-amine,5-[3-(phenylmethoxy)phenyl]-7-(5-thiazolyl)-

Ethanone,1-[3,5-bis(acetyloxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-,hydrobromide

Imidazolidinetrione, [(3-fluorophenyl)methyl]-

Ethanone,1-[3-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-1,4-dioxido-2-quinoxalinyl]-

Formic acid, compd. with1-amino-N-(2-methylphenyl)cyclohexanecarboxamide (1:1)

672959-88-5

Benzaldehyde, acetyl-

6-bromo-4-(2-methoxyethoxy)quinoline

1-Piperazinecarboxylic acid,4-[[4-[2-[(4-methoxyphenyl)amino]-4-pyrimidinyl]phenyl]sulfonyl]-,1,1-dimethylethyl ester

Imidazolidine, 4,5-bis(1,1-dimethylethyl)-1,3-bis[(1S)-1-phenylethyl]-,(4R,5R)-

Imidazolidine, 4-[(2,4,6-trimethylphenyl)methylene]-

Imidazolidine, 2-(nitromethylene)-1-[(5-phenoxy-2-furanyl)methyl]-

105828-63-5

Ethanone,1-[4-(methylsulfonyl)phenyl]-2-(5,6,7,8-tetrahydro-2-naphthalenyl)-

Formic acid, compd. withN-(3S)-1-azabicyclo[2.2.2]oct-3-yl-5-ethyl-1H-indazole-3-carboxamide(1:1)

1-Naphthalenamine, 2-[(1E)-2-phenyl-1-propenyl]-

5-BROMO-2,4-DIFLUOROBENZOIC ACID 97%

2-[(3S,4S,5S,6R)-7-HYDROXY-4,6-DIMETHOXY-3,5-DIMETHYLHEPTYL]-5,7-DIMETHOXY-8-(METHOXYMETHOXY)-3-METHYL-2,3-DIHYDRO-4H-1-BENZOPYRAN-4-ONE

Imidazo[5,1-f][1,2,4]triazin-2-amine,7-(5-bromo-2-thienyl)-N-(4-methoxyphenyl)-5-methyl-

774462-03-2

Imidazolidine, 2-[nitro[(4-nitrophenyl)azo]methylene]-

Benzonitrile, 3-amino-2-(1,4-dioxaspiro[4.5]dec-8-ylidenemethyl)-

2'-deoxyuridine-5-3H radiochemical*purity: approx

Formic acid, compd. withN-(3S)-1-azabicyclo[2.2.2]oct-3-yl-5-[[(4-methoxyphenyl)acetyl]amino]-1H-indazole-3-carboxamide (1:1)

Ethanone,1-[3-[[4-(4-nitrophenyl)-1-piperazinyl]methyl]-1,4-dioxido-2-quinoxalinyl]-

Formic acid, compd. with O-(4-chlorophenyl)methyl[4-[[6-(methyl-2-propenylamino)hexyl]oxy]phenyl]carbamothioate(1:1)

391911-59-4